157 related articles for article (PubMed ID: 27721068)
1. Molecular simulation study of the unbinding of α-conotoxin [ϒ4E]GID at the α7 and α4β2 neuronal nicotinic acetylcholine receptors.
Suresh A; Hung A
J Mol Graph Model; 2016 Nov; 70():109-121. PubMed ID: 27721068
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of α-conotoxin GID analogues as selective α4β2 nicotinic acetylcholine receptor antagonists.
Banerjee J; Yongye AB; Chang YP; Gyanda R; Medina-Franco JL; Armishaw CJ
Biopolymers; 2014 Jan; 102(1):78-87. PubMed ID: 24122487
[TBL] [Abstract][Full Text] [Related]
3. Interactions of Globular and Ribbon [γ4E]GID with α4β2 Neuronal Nicotinic Acetylcholine Receptor.
Wu X; Craik DJ; Kaas Q
Mar Drugs; 2021 Aug; 19(9):. PubMed ID: 34564144
[TBL] [Abstract][Full Text] [Related]
4. Effects of C-Terminal Carboxylation on α-Conotoxin LsIA Interactions with Human α7 Nicotinic Acetylcholine Receptor: Molecular Simulation Studies.
Wen J; Hung A
Mar Drugs; 2019 Apr; 17(4):. PubMed ID: 30987002
[TBL] [Abstract][Full Text] [Related]
5. Efficient binding of 4/7 α-conotoxins to nicotinic α4β2 receptors is prevented by Arg185 and Pro195 in the α4 subunit.
Beissner M; Dutertre S; Schemm R; Danker T; Sporning A; Grubmüller H; Nicke A
Mol Pharmacol; 2012 Oct; 82(4):711-8. PubMed ID: 22802270
[TBL] [Abstract][Full Text] [Related]
6. Species specificity of rat and human α7 nicotinic acetylcholine receptors towards different classes of peptide and protein antagonists.
Yu J; Zhu X; Zhang L; Kudryavtsev D; Kasheverov I; Lei Y; Zhangsun D; Tsetlin V; Luo S
Neuropharmacology; 2018 Sep; 139():226-237. PubMed ID: 30025921
[TBL] [Abstract][Full Text] [Related]
7. Alpha-conotoxin OmIA is a potent ligand for the acetylcholine-binding protein as well as alpha3beta2 and alpha7 nicotinic acetylcholine receptors.
Talley TT; Olivera BM; Han KH; Christensen SB; Dowell C; Tsigelny I; Ho KY; Taylor P; McIntosh JM
J Biol Chem; 2006 Aug; 281(34):24678-86. PubMed ID: 16803900
[TBL] [Abstract][Full Text] [Related]
8. Investigation of α-conotoxin unbinding using umbrella sampling.
Yu R; Tabassum N; Jiang T
Bioorg Med Chem Lett; 2016 Feb; 26(4):1296-300. PubMed ID: 26796065
[TBL] [Abstract][Full Text] [Related]
9. Novel 2-(substituted benzyl)quinuclidines inhibit human α7 and α4β2 nicotinic receptors by different mechanisms.
Arias HR; López JJ; Feuerbach D; Fierro A; Ortells MO; Pérez EG
Int J Biochem Cell Biol; 2013 Nov; 45(11):2420-30. PubMed ID: 23954208
[TBL] [Abstract][Full Text] [Related]
10. Blockade of Human α7 Nicotinic Acetylcholine Receptor by α-Conotoxin ImI Dendrimer: Insight from Computational Simulations.
Xu X; Liang J; Zhang Z; Jiang T; Yu R
Mar Drugs; 2019 May; 17(5):. PubMed ID: 31126085
[TBL] [Abstract][Full Text] [Related]
11. Discovery of peptide ligands through docking and virtual screening at nicotinic acetylcholine receptor homology models.
Leffler AE; Kuryatov A; Zebroski HA; Powell SR; Filipenko P; Hussein AK; Gorson J; Heizmann A; Lyskov S; Tsien RW; Poget SF; Nicke A; Lindstrom J; Rudy B; Bonneau R; Holford M
Proc Natl Acad Sci U S A; 2017 Sep; 114(38):E8100-E8109. PubMed ID: 28874590
[TBL] [Abstract][Full Text] [Related]
12. Blockade of neuronal α7-nAChR by α-conotoxin ImI explained by computational scanning and energy calculations.
Yu R; Craik DJ; Kaas Q
PLoS Comput Biol; 2011 Mar; 7(3):e1002011. PubMed ID: 21390272
[TBL] [Abstract][Full Text] [Related]
13. Determination of alpha-conotoxin binding modes on neuronal nicotinic acetylcholine receptors.
Dutertre S; Nicke A; Tyndall JD; Lewis RJ
J Mol Recognit; 2004; 17(4):339-47. PubMed ID: 15227641
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of neuronal nicotinic acetylcholine receptor subtypes by alpha-Conotoxin GID and analogues.
Millard EL; Nevin ST; Loughnan ML; Nicke A; Clark RJ; Alewood PF; Lewis RJ; Adams DJ; Craik DJ; Daly NL
J Biol Chem; 2009 Feb; 284(8):4944-51. PubMed ID: 19098004
[TBL] [Abstract][Full Text] [Related]
15. Alpha-conotoxin analogs with additional positive charge show increased selectivity towards Torpedo californica and some neuronal subtypes of nicotinic acetylcholine receptors.
Kasheverov IE; Zhmak MN; Vulfius CA; Gorbacheva EV; Mordvintsev DY; Utkin YN; van Elk R; Smit AB; Tsetlin VI
FEBS J; 2006 Oct; 273(19):4470-81. PubMed ID: 16956365
[TBL] [Abstract][Full Text] [Related]
16. Hydrophobic residues at position 10 of α-conotoxin PnIA influence subtype selectivity between α7 and α3β2 neuronal nicotinic acetylcholine receptors.
Hopping G; Wang CI; Hogg RC; Nevin ST; Lewis RJ; Adams DJ; Alewood PF
Biochem Pharmacol; 2014 Oct; 91(4):534-42. PubMed ID: 25101833
[TBL] [Abstract][Full Text] [Related]
17. Dimerization of α-Conotoxins as a Strategy to Enhance the Inhibition of the Human α7 and α9α10 Nicotinic Acetylcholine Receptors.
Liang J; Tae HS; Xu X; Jiang T; Adams DJ; Yu R
J Med Chem; 2020 Mar; 63(6):2974-2985. PubMed ID: 32101438
[TBL] [Abstract][Full Text] [Related]
18. Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions.
Huang X; Zheng F; Chen X; Crooks PA; Dwoskin LP; Zhan CG
J Med Chem; 2006 Dec; 49(26):7661-74. PubMed ID: 17181149
[TBL] [Abstract][Full Text] [Related]
19. Engineered Conotoxin Differentially Blocks and Discriminates Rat and Human α7 Nicotinic Acetylcholine Receptors.
Wang S; Zhu X; Zhangsun M; Wu Y; Yu J; Harvey PJ; Kaas Q; Zhangsun D; Craik DJ; Luo S
J Med Chem; 2021 May; 64(9):5620-5631. PubMed ID: 33902275
[TBL] [Abstract][Full Text] [Related]
20. Delineation of the unbinding pathway of α-conotoxin ImI from the α7 nicotinic acetylcholine receptor.
Yu R; Kaas Q; Craik DJ
J Phys Chem B; 2012 May; 116(21):6097-105. PubMed ID: 22571488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
